AR057853A1 - Composicion farmaceutica que logra una excelente absorbencia de la sustancia farmacologicamente activa - Google Patents

Composicion farmaceutica que logra una excelente absorbencia de la sustancia farmacologicamente activa

Info

Publication number
AR057853A1
AR057853A1 ARP060104810A ARP060104810A AR057853A1 AR 057853 A1 AR057853 A1 AR 057853A1 AR P060104810 A ARP060104810 A AR P060104810A AR P060104810 A ARP060104810 A AR P060104810A AR 057853 A1 AR057853 A1 AR 057853A1
Authority
AR
Argentina
Prior art keywords
active substance
pharmacologically active
pharmaceutical composition
absorbence
achieves excellent
Prior art date
Application number
ARP060104810A
Other languages
English (en)
Inventor
Yuso Tomohira
Takakuni Matsuda
Yasuo Yamaguchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR057853A1 publication Critical patent/AR057853A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente brinda una composicion farmacéutica que puede lograr eficazmente su actividad medicinal por tener una excelente absorbencia de la substancia farmacologicamente activa básica, incluso cuando la substancia farmacologicamente activa básica es escasamente soluble, y la composicion farmacéutica se prepara agregando (i) una substancia farmacologicamente activa básica con (ii) un éster de glicerol de ácido graso y ácido orgánico y/o un éster de poliglicerol de ácido graso y ácido orgánico.
ARP060104810A 2005-11-04 2006-11-02 Composicion farmaceutica que logra una excelente absorbencia de la sustancia farmacologicamente activa AR057853A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005321191 2005-11-04

Publications (1)

Publication Number Publication Date
AR057853A1 true AR057853A1 (es) 2007-12-19

Family

ID=38005891

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104810A AR057853A1 (es) 2005-11-04 2006-11-02 Composicion farmaceutica que logra una excelente absorbencia de la sustancia farmacologicamente activa

Country Status (5)

Country Link
US (1) US8796309B2 (es)
JP (1) JP5441337B2 (es)
AR (1) AR057853A1 (es)
TW (1) TW200800268A (es)
WO (1) WO2007052738A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5283654B2 (ja) * 2010-03-30 2013-09-04 中日本カプセル 株式会社 ソフトカプセル用の充填組成物
CN109996561A (zh) * 2016-11-30 2019-07-09 狮王株式会社 内服剂
US20210251902A1 (en) * 2018-06-11 2021-08-19 Otsuka Pharmaceutical Co., Ltd. Delamanid-containing composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0623092B2 (ja) 1984-03-19 1994-03-30 太陽化学株式会社 坐薬用医薬組成物
JPH0739347A (ja) 1993-07-28 1995-02-10 Riken Vitamin Co Ltd 冷凍魚肉すり身の品質改良剤
JPH10231254A (ja) 1996-12-19 1998-09-02 Dai Ichi Seiyaku Co Ltd 経口吸収改善医薬用組成物
JP2000024487A (ja) * 1998-07-10 2000-01-25 Nisshin Oil Mills Ltd:The 油性組成物を含有した乳化組成物
JP2000026283A (ja) * 1998-07-10 2000-01-25 Nisshin Oil Mills Ltd:The 油性組成物を含有した粉末組成物
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
JP2001316259A (ja) 2000-05-01 2001-11-13 Taiyo Kagaku Co Ltd ポリフェノール類製剤
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
WO2004064543A1 (ja) 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
JP4444586B2 (ja) * 2003-06-10 2010-03-31 太陽化学株式会社 コエンザイムｑ１０含有組成物

Also Published As

Publication number Publication date
US20090227630A1 (en) 2009-09-10
JP5441337B2 (ja) 2014-03-12
US8796309B2 (en) 2014-08-05
WO2007052738A1 (ja) 2007-05-10
JPWO2007052738A1 (ja) 2009-04-30
TW200800268A (en) 2008-01-01

Similar Documents

Publication Publication Date Title
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
PE20080331A1 (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
ECSP10010735A (es) Compuestos químicos 251
MX2009006088A (es) Nanoemulsion.
CL2007003000A1 (es) Compuestos derivados de biaril eter urea; composicion farmaceutica que los contienen; y su uso para el tratamiento de enfermedades o afecciones asociadas a la actividad de amida hidrolasa de acidos grasos (faah).
CL2008000594A1 (es) Uso de compuestos derivados de heterociclos; composicion farmaceutica que comprende a dichos compuestos y otros agentes activos; y su uso para tratar diabetes, enfermedad arterial coronaria entre otras enfermedades.
CL2009000541A1 (es) Uso de una enzima degradadora de matriz activable (amde) para la formulacion de un medicamento de administracion sub-epidermica; composicion farmacologica y su uso; combinacion que comprende a amde, un activador y un agente; recipiente para amde y para el activador; kit que comprende dicho recipiente
AR047928A1 (es) Derivados de tetrahidropiridoindol
BRPI0510684A (pt) composições para adiministração tópica ou transdérmica de agente anticolinérgico ou antiespasmódico e uso dos respectivos compostos
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
BRPI0518191A (pt) métodos e composições para reduzir a toxicidade de um composto farmacêutico
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
EA200501819A1 (ru) Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке
ATE549016T1 (de) Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
MX2007006775A (es) Composiciones estables de fenofibrato con esteres de acido graso.
ECSP056186A (es) Composición farmacéutica en forma de hidrogel para administración transdérmica de sustancias activas
AR057853A1 (es) Composicion farmaceutica que logra una excelente absorbencia de la sustancia farmacologicamente activa
UY27727A1 (es) Nueva composicion farmacéutica-
BRPI0418070A (pt) composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite
AR059225A1 (es) Sal de citrato, proceso de preparacion y su actividad en terapia
AR031316A1 (es) Compuestos antitumorales activados por fap ii
AR040287A1 (es) Plataforma para formulaciones transdermicas (pft)
DE602004014964D1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel

Legal Events

Date Code Title Description
FB Suspension of granting procedure